MXC.AX - MGC Pharmaceuticals Limited

ASX - ASX Delayed price. Currency in AUD
Show:
Income statement
Balance sheet
Cash flow

Income statement

Annual
All numbers in thousands
Revenue30/06/201930/06/201830/06/201730/06/2016
Total revenue656.237296.811120.2422.197
Cost of revenue356.642119.34158.07315.011
Gross profit299.595177.471-37.831-12.814
Operating expenses
Research development2,538.554951.323951.323951.323
Selling general and administrative5,260.1034,282.9814,537.6472,273.032
Non-recurring----
Others415.781595.358339.815159.24
Total operating expenses9,367.8287,349.7957,409.9844,219.753
Operating income or loss-8,711.591-7,052.984-7,289.742-4,217.556
Income from continuing operations
Total other income/expenses net7,037.084-1,937.486-1,212.283-2,012.507
Earnings before interest and taxes-8,711.591-7,052.984-7,289.742-4,217.556
Interest expense-8-99.369-19.724-120.006
Income before tax-1,876.357-8,990.47-8,502.025-6,230.063
Income tax expense27.315---
Minority interest-161.163-1,241.793-444.637-80.652
Net income from continuing ops-1,903.672-8,990.47-8,502.025-6,230.063
Non-recurring events
Discontinued operations-450.1851.0381.0381.038
Extraordinary items----
Effect of accounting changes----
Other items----
Net income
Net income-2,309.332-8,246.34-8,144.361-6,157.144
Preferred stock and other adjustments----
Net income applicable to common shares-2,309.332-8,246.34-8,144.361-6,157.144